pfizer's new low dose vaccine for children 6 months to 5 years old. how soon could there be a decision? what we've learned tonight. more than 808,000 children testing positive for covid last week. >>> tonight, this new storm. more than 20 states now on alert from colorado to texas to new york, and all of the northeast. heavy snow, dangerous ice and bitter cold. the storm coming in two rounds and ginger zee explains with this newest track tonight. >>> the emergency evacuations. the massive fire at a fertilizer plant in north carolina. more than 6,000 people forced from their homes. firefighters pulling back more than a mile because of fears of a possible explosion. >>> a deadly school shooting in minnesota. one student killed, another in critical condition. and another shooting, this time at a virginia campus. two officers shot. >>> overseas tonight, more u.s. military equipment arriving in ukraine and tonight, vladimir putin and his new message about the u.s. and nato, saying, quote, they played us. >>> the january 6th investigation. new reporting ton

of confidence from the pfizer team. luz: luz pena, abc 7 news. dan: a new bill would compel every californian worker to get vaccinated against covid-19. the proposal would require businesses to make sure employees are in compliance. ryan curry explains that the bill, as you can imagine, is getting mixed reaction. reporter: every worker in california vaccinated against covid-19. that is the goal of a new bill proposed by buffy wicks. >> people have been experiencing so much whiplash when it comes to testing guidelines and mask mandates and vaccine guidance. reporter: at a press conference friday, wicks says it should ensure a safer barrier against covid-19. if it passes, all businesses would require employees and contractors to get the vaccine. it comes after the supreme court ruled against a vaccine proposed by the biden administration, but makes thanks this plan is legal. >> we know enough at this point about the pandemic that we can make this happen together. reporter: this plan is being met with mixed reviews. >> i d

today pfizer says it wants to make vaccines available to the very youngest. recent data from the american aacademy shows 11 million pediatric cases of covid-19 in the united states. since the start of the pandemic. 2 million of the cases added in just the past two weeks. child cases represent more than 18% of all cases. today pfizer is asking the fda to expand its use of the covid-19 vaccine to kids between ages six months to five years. children under five are the only group in the u.s. who cannot get the vaccine right now. >> pfizer announcement is the moment millions of parents have been waiting for. nervous about their kids getting covid. it's a vaccine that is already been given to some bay area toddlers. >> today we talked with a bay area mom. who two sons both under age 5 received the pfizer covid vaccine. for that age range. during clinical trials. just seven months old when he received the pfizer covid vaccine. developed for children under five. as part of the clinical trial. at stanford. three year-old big brother also received two doses of the vacc

the fda kind of asking to see this information from pfizer when we knew going into this, pfizer didn't necessarily have that data, because they had told us way back when this was going to be a three-dose regimen and they were studying that. what do you make of that? >> yeah, i don't know -- i kind of side with what dr. murthy said here. i wouldn't look at it as an interference because a lot of times, you do have that conversation, ongoing conversation, particularly in a public health crisis between regulators and those that might be making a potential intervention that's going to help that public health emergency. but the issue is the data, as you mentioned, that pfizer released in december, there were two issues there. one was that they didn't see an efficacy or they didn't see the milestones that they wanted to reach, which is what they were trying to do there is something called immunobridging. they were looking at what immune markers they should look in the blood that they've seen in older kids who have been protected to be able to show that in younger kids to predict that those ki

of confidence from the pfizer team. luz: luz pena, abc 7 news. dan: a new bill would compel every californian worker to get vaccinated against covid-19. the proposal would require businesses to make sure employees are in compliance. ryan curry explains that the bill, as you can imagine, is getting mixed reaction. reporter: every worker in california vaccinated against covid-19. that is the goal of a new bill proposed by buffy wicks. >> people have been experiencing so much whiplash when it comes to testing guidelines and mask mandates and vaccine guidance. reporter: at a press conference friday, wicks says it should ensure a safer barrier against covid-19. if it passes, all businesses would require employees and contractors to get the vaccine. it comes after the supreme court ruled against a vaccine proposed by the biden administration, but makes thanks this plan is legal. >> we know enough at this point about the pandemic that we can make this happen together. reporter: this plan is being met with mixed reviews. >> i d

did they not have the data ready, pfizer? >> so pfizer submits the data to the fda. the fda pulls a team of people together who work pretty much around the clock to look at all the data, every piece of clinical information for every child that got vaccine or placebo and they put together their own document and then those two documents go to the fda vaccine advisory committee usually days before the meeting. >> so the fda is putting together their study after having received pfizer's study, is that right? >> right. they want to make sure that pfizer hasn't left out any information or misrepresented information. they want to make sure that they look at all the data, every single piece of information, and not accept pfizer's summary of those. >> i totally understand. this is a different approach than past vaccine recommendations because pfizer is asking the fda to review this two-shot regimen when they already know that a third shot will likely be needed for optimal immunity. do you agree with this method? i guess it's being done in the name of speed and helping these k

pfizer's new low dose vaccine for children 6 months to 5 years old. how soon could there be a decision? what we've learned tonight. more than 808,000 children testing positive for covid last week. >>> tonight, this new storm. more than 20 states now on alert from colorado to texas to new york, and all of the northeast. heavy snow, dangerous ice, and bitter cold. the storm coming in two rounds and ginger zee explains with this newest track tonight. >>> the emergency evacuations. the massive fire at a fertilizer plant in north carolina. more than 6,000 people forced from their homes. firefighters pulling back more than a mile because of fears of a possible explosion. >>> a deadly school shooting in minnesota. one student killed, another in critical condition. and another shooting, this time at a virginia campus. tw officers shot. >>> overseas tonight, more u.s. military equipment arriving in ukraine and tonight, vladimir putin and his new message about the u.s. and nato, saying, quote, they played us. >>> the january 6th investigation. new reporting ton

pfizer is testing three shots. one thing the doctor says is clear is safety. >> we haven't seen any concerns about safety. so that's always the big issue, the main point -- is this vaccine safe? it looks extremely safe so far. and we don't anticipate that it will change in this age group. reporter: in the coming weeks, the fda may consider authorizing two shots, with a third shot being cleared later on if the study supports. once the fda approves it, it has to be cleared by the cdc. a moment parents can't wait for. >> the relief of knowing we can go to a restaurant or the library, we can go on a flight. while he still may get it, he is still more productive, and the symptoms will be reduced if he has the vaccination. ama: many writers may have dealt with delays today. officials say that there are ongoing staffing issues that could impact 21 routes. they are asking people to consider alternative options for transportation. delays were expected yesterday and through the early afternoon today. last month, muni was exp

shares of pfizer lower. details next. this is bloomberg. ♪ >> a look at the biggest business stories in the news. i am ritika guba debt. big changes on the way at peloton. share prices plunged after a slow down and demand. john foley is stepping down as ceo and will become the executive chair. he will be replaced by the former cfo at spotify barry mccarthy. it is seen as a victory for blackwell capital. 2800 jobs will be cut. the australian electric vehicle company will build its third u.s. factory in tennessee. president biden will make the announcement today. it will be located east of nashville and create 500 jobs and make as many as 30,000 electric charges a year. pfizer forecast 2022 profits that fell short. expectations for the vaccine and therapy disappointed investors by the $100 billion target. it would mark a record high for the company. that is your latest business flash. guy: let's pick up on the pfizer story and talk about it more. originally very bullish and you wonder how we ended up with his gap and expe

pfizer's vaccine for children under 5, both pfizer and the fda delaying this? what is driving this? also, news on the third booster that millions of adults received in this country. what they saw during the omicron wave. how soon the booster wanes. is a fourth shot possible? here's stephanie ramos. >> reporter: tonight, a stunning reversal. just days before an expert panel was set to meet, the fda and pfizer announcing regulators will need more time before deciding whether to authorize the vaccine for children under 5. >> at this time, it makes sense for us to wait until we have the data from the evaluation of a third dose before taking action. >> reporter: pfizer had signaled that three doses of the vaccine will be needed, after two doses failed to produce a strong immune response in 2 to 4-year-olds. but the trial data from that third dose won't be available until early april. >> pulling back right now, getting the data is the right thing to do. it should be encouraging that we're not trying to push this too quickly. >> reporter: but the delay is a setback for millions of parents

murthy will discuss pfizer's vaccine application for kids under the age of five. and then i'll cover operational planning so that we're ready for that age group. with that, over to dr. walensky. dr. walensky? dr. walensky: thank you, jeff. good afternoon. i'd like to start by walking you through today's data. the current seven-day daily average of cases is about 446,400 cases per day, a decrease of about 36% over the previous week. the seven-day average of hospital admissions is about 17,100 per day, also a decrease of about 14% over the previous week. and the seven-day average daily deaths are about 2,300 per day, which is an increase of about 4% over the prior week. while we continue to see large decreases in average daily case counts across the country, hospitalizations remain high, stretching our healthcare capacity and workforce to its limits in some areas of the country. and daily deaths also remain quite high. and with the mixed news above, similar to other waves during the pandemic, our data continue to reinforce the critical importance of vaccination. las

pfizer's vaccine for children under 5, both pfizer and the fda tonight now delaying this, so what is driving this? and we also have news this evening on that third booster that millions of adults received in this country. what they saw during the omicron wave. how soon the booster wanes ad does this now mean a fourth shot is possible? here's abc's stephanie ramos tonight. >> reporter: tonight, a stunning reversal. just days before an expert panel was set to meet, the fda and pfizer announcing regulators will need more time before deciding whether to authorize the vaccine for children under 5. >> all done. you're done. >> at this time, it makes sense for us to wait until we have the data from the evaluation of a third dose before taking action. >> reporter: pfizer had signaled that three doses of the vaccine will be needed, after two doses failed to produce a strong immune response in 2 to 4-year-olds. but the trial data from that third dose won't be available until early april. >> pulling back right now, getting all the data is the right thing to do. it should be encouraging that we

pfizer has asked the u.s. to authorize extra low doses of its covid vaccine for kids ages 4 that the 6 months this means these young kids could start getting shots as early as late february or early march. we spoke with local doctors about what this means for children and the pandemic in general. we will have much more about that coming up in a full report tonight at 5.15. >> as of today, san francisco is easing its mask restrictions, although that does not mean they're going away. in fact, and most places they will remain in place. basically means in locations where stable groups of people gathered like a gym. >> or an office, folks there can take their masks off if everyone has all their available shots. kron four's dan kerman joins us live in san francisco. dan, if i'm understanding this correctly, this is just a version of a policy that was in place pre omicron. but now you have to be boosted. is that right? you have to be boosted. if you're eligible to be boosted in. basically, are finding this a lot of w

pfizer seeks approval to inoculate children under 5. why some kids may need three shots. >>> well, good morning, and good to be with you. i'm anne-marie green. this morning more than 90 million people in 21 states are in the path of a massive winter storm. the national weather service has issued winter storm warnings or watches stretching all the way from new mexico to maine. the system is expected to bring heavy snow, sleet, and freezing rain to many areas that saw another crippling storm just a few days ago. nearly 3,000 scheduled flights have already been canceled in the u.s. for today and tomorrow. the south is expected to bear the brunt of a potentially dangerous ice storm. the governor of texas says his state is working around the clock to prepare, and it comes nearly a year after a catastrophic winter storm devastated the state's power grid causing hundreds of deaths. in parts of michigan shoppers cleared out grocery store shelves getting ready for the worst. >> we're out doing some shopping and stocking up on some things just in

tonight, pfizer asking the f.d.a. for emergency use authorization for its vaccine for children ages six months to four years old. now, this comes earlier than expected. the company says it was asked to submit its data after a record number of kids got covid last month. the american academy of pediatrics says more than 3.5 million children tested positive for covid in january alone. and parents nationwide have been pushing for an expansion of shots for babies, toddlers, and preschoolers, especially in the wake of the fast-moving omicron variant that also resulted in a record number of pediatric hospitalizations. cbs' nikki battiste joins us now with this late-breaking news. good evening, nikki. >> reporter: norah, good evening. pfizer says tonight it has given the f.d.a. data on a two-dose vaccine regimen for children ages six months through four years old. the doses are one-tenth of an adult's and would be given three weeks apart. pfizer says it also plans to submit data on a third shot for this age group soon. pfizer

the -- the -- the fda rushed through pfizer's vaccine application. there have been lawsuits trying to get access to what the data that pfizer submitted to the fda. and the fda has said it's going to take them 75 years to fully release the information which they used to rush through the authorization for the pfizer covid vaccine. i mean, this is a joke. but there are so many jokes at several -- at every level in this pandemic. for instance, i was -- you know, some folks my be offended by my views but i want to make it clear that i'm following this interview -- following the california covid safety guidelines. at the nfc playoffs a couple of weekends ago governor newsom was there. newsom has imposed one of the strictest lockdowns -- one of the strictest mask mandates in the country. kids have got to wear them around the clock, practically, indoor places you have to have them. newsom and the mayors of l.a. and san francisco were photographed at that football game not wearing masks. and so newsom was challenged on it afterwards, newsom said, well, it was

actually did step into the game that the other companies, they lost little boy have been for pfizer one of the biggest - so it makes you wonder about that sort of it, and view the vaccines are not common been actually maybe are one is working on the book, brendan borrell actually get the data to look at how much the companies profit, that was actually pretty tough. that you're going to make money from rare diseases and f cancer medicines but clearly a big disease like this is a good example. >> even if they have all of the intentions of having that market is sose important because specially diseases are much bigger problem. and recently run about that malaria vaccine, 230 years there almost no players in that the financing is going to be so difficult pretty basically, committed to buying millions of doses so the kids can live in the severity and it's great when they work out for us but it doesn't seem like a set up to help people when it does not affect the entire world. >> the other example is the hiv vaccine which is been such a scientific challenge it then that is a much more dif

the fda vaccine advisory committee will meet february 15th to discuss pfizer's request and the data. >> we have not seen anything unusual here. and of course, we have thousands of kids across the country enrolled. but the company did call us together last week and assured us they reviewed all the data so far and they have not seen any safety concerns. >> if the fda grants emergency use approval, kids under 5 could start getting the vaccine as early as next month. nbc bay area news. >> well, thanks to a really wet december, our snow pack remains slightly above average. december helped offset an extremely dry january. survey conducted near south lake tahoe reported 48 1/2 inches of snow. that's 109% above average for that area on december 1st. we need more rain to come back. after december, snow levels were more than 200% above average. we're going to need a wet february. >> or a march miracle. miracle march. things aren't looking very promising for us. as we continue our climate coverage tonight, i wanted to show you what's happening in the pacific. you can see there is storm activity

go back the past couple years for pfizer thank you. we appreciate that >>> finally today, earnings exchange, the beauty retailer coty has been big in terms of moving on earnings big revenue growth and rosy guidance but the shares down 18% to start 2022. kristina has the story >> the first thing we'll be looking at is holiday sales. coty has roughly 25% that come from holidays. will they do well, especially when a competitor had a 30% increase just in the quarter alone. the second avenue is just segment growth within certain products like cover girl last year there was a few viral cover girl tiktok videos and the ceo has said that they are putting momentum behind cover girl, especially heading into this year. and then we can't discount the strength of the kardashians. coty owns 50% of kylie jenner's line and some of the cons for the stock, the fact it has less exposure to skin care with higher margins and less exposure to china >> all right >> not only is it down to start the year down over the last seven years as well. so really an emb

now the fda says it asked pfizer to submit the data it has on two doses while pfizer collects more information on a third shot. the agency scheduled a meeting of its vaccine advisers february 15th to discuss the application which would set up potential clearance of two doses of this vaccine by the end of the month. now, a key question is why would the fda consider the vaccine now if the immune response was found to be insufficient with two doses. the reporting from the "washington post" suggests that pfizer's data show the vaccine has a good safety profile, and showed an ability to prevent a significant number of covid-19 ca cases. those results should be published a few days before the fda meeting. pfizer's ceo said in a statement today that while the company believes three doses will be needed to provide high levels of protection, quote, if two doses are authorizes, parents will have the opportunity to again a covid-19 vaccination series for their children while awaiting potential authorization of a third dose now, experts i've spoken with about this say a lot depends on what the data actual

reportera: pfizer pidiÓ la autorizaciÓn de su vacuna. pide que se le "dedos" ——dÉ dos dosis mientras pfizer sigue probando la tercera dosis. el paciente no es al que hay que convencer de vacunarse, sino mÁs bien a los padres de ese paciente, y allÍ las opiniones estÁn divididas. ella estÁ ansiosa porque sus nietos mÁs pequeÑos se vacunen. >> yo me sentirÍa con mÁs confianza si ya sÉ que ellos estÁn protegidos. reportera: a los moreno la idea no les atrae. >> esperarÍa a que vacunen mÁs niÑos a ver quÉ pasa. >> nos preocupa mucho con los niÑos pequeÑos la aprobaciÓn sin las pruebas suficientes en este momento. yo por ahora no lo harÍa. reportera: la vacuna de pfizer ya estÁ autorizado para su uso en niÑos de 5 aÑos en adelante. si Ésta se autoriza, serÍa la primera vacuna disponible para niÑos mÁs pequeÑos. >> ya vacunamos a millones de niÑos mayores de 5 aÑos, las escuelas y lugares donde mÁs vacunas hay, menos complicaciones, menos covid, menos idas al hospital por covid tienen. reportera: se espera que

do you think pfizer may have jumped the gun here? >> i think pfizer took a gamble and are now realizing that gamble was probably not the right decision and are rethinking their strategy. >> reporter: for adults, each dose is 30 micrograms. for children, each dose is three. pfizer said two doses for those kids didn't generate strong enough immune response in the trial, but days ago, the pfizer ceo seemed confident the fda would sign off on two doses while awaiting more data for a third. >> i think they will be pleased with the data and they will approve. >> reporter: but the wait now drags on for families like this one who have a three yield son, bailey. >> it is frustrating. we looked forward to having him vaccinated as soon as we could. >> reporter: they expect data for the third dose by early april. it could be two months before the vaccine is authorized. meanwhile, moderna said they could have data for kids two to five years old by march. >> gabe joining me in the studio. there's also news on booster shots. what have we learned? >

pfizer planea tener la informaciÓn sobre la tercero dosis lista a principios de abril. el retraso le darÁ tiempo a la fda para evaluar la efectividad de la vacuna. el gobierno dice tener listas de millones de dosis para cuando eventualmente sea aprobada. en san francisco, luis, univisiÓn. jorge: hay masa sobre este tema, refuerzo de la vacuna contra del covid—19 pierde efectividad despuÉs de cuatro meses aunque previene la hospitalizaciÓn de quienes los reciben. este estudio concluyÓ que tanto el refuerzo de pfizer como el de moderna pierden vigencia al cabo de 120 dÍas. el gobierno aprobÓ un tratamiento de anticuerpos monoclonales de laboratorio lily que parece funcionar contra el omicron, imitan la capacidad del sistema inmunolÓgico para combatir infecciones peligrosas como el coronavirus. patricia: en canadÁ la autoridades de ontario declararon el estado de emergencia en respuesta a los bloqueos de camiones en ottawa y los puentes que unen a este paÍs con estados unidos, dijeron que adoptarÁn una legislaciÓn para castigar a los que estÁn interfiriendo

pfizer is ready to offer the shot to children as young as 6 months old. the approval is still sign your kids up. >> plus, requiring proof. east bay city now asking all customers to show vaccine cards when entering restaurants and businesses starting today. this is "today in the bay." >>> a very good tuesday morning to you, and thanks so much for starting your day with us. i'm laura garcia. >> and i'm marcus washington. we're broadcasting on your television, but we're also broadcasting live for you on a lot of different places. roku, amazon fire, apple tv and online at nbcbayarea.com. first, we want to get a look at the forecast and commute. we'll start with meteorologist kari hall with what we can expect today. >> yeah, you'll need two hands tightly gripping the steering wheel today because it's going to be very windy. we have wind advisories in effect for much of the bay area and nor the north bay a high wind warning where gusts could reach 60 miles per hour. and because of the dry weather we've had recently, we could have a high fire danger. not only th

why is pfizer pulling their fda application? >> millions of parents who were waiting on this, they're going to have to wait a little longer. just within the past few minutes the company saying they plan to extend their rolling submission to the fda, essentially pulling the emergency use authorization application because you might remember next week an fda advisory panel was set to meet on tuesday to discuss this. and typically how this played out is the fda advisory panel would discuss it and then if they voted for emergency use authorization, then the cdc would take a look at this. the cdc had said that it was possible if everything went well to have shots in arms by president's day. earlier this week pfizer's ceo seemed confident that the fda would take a look at this and authorize this. as you mentioned just yesterday president biden told lester we were on the verge of this as well. so this is a significant change. so why, you know, what's the significance here in terms of why didn't they wait until submitting this emergency

tonight, pfizer asking the f.d.a. for emergency use authorization for its vaccine for children ages six months to four years old. now, this comes earlier than expected. the company says it was asked to submit its data after a record number of kids got covid last month. the american academy of pediatrics says more than 3.5 million children tested positive for covid in january alone. and parents nationwide have been pushing for an expansion of shots for babies, toddlers, and preschoolers, especially in the wake of the fast-moving omicron variant that also resulted in a record number of pediatricning,. >> reporter: norah, good evening. pfizer says tonight it has given the f.d.a. data on a two-dose vaccine regimen for children ages six months through four years old. the doses are one-tenth of an adult's and would be given three weeks apart. pfizer says it also plans to submit data on a third shot for this age group soon. pfizer's request for emergency use authorization of its vaccines means one of the nation's youngest ag

>> so society's gain could be pfizer's loss. is the action in the stock almost telling us that, you know, that we're not going to be like this forever? >> yeah. i mean, it's actually saying to you we are going to be reopening, so two things one is we might not need your vaccines as much, and by the way if we do we're not going to be paying as much because now we've got other competitors out there, and the demand is going to be such that all the governments in the world are going to actually put pressure on what you can charge because you do have moderna and for the others so you're basically discounted and if you have another issue then all of a sudden the demand comes really up in the six months so it's really do you look to the future or say, hey, this company is keep on producing what it's doing right now? >> yeah, they need something people get every year, something that doesn't kill you that people get every year. and this is all or nothing with covid. you can't -- obviously that's not being valued very highly by the market

the fda gave full approval to pfizer's vaccine last august. >>> we are watching the wind. it is about to pick up again and it could cause problems. jeff, we've had this dangerous combination a couple weeks ago. no rain and these winds. >> very dangerous for us even though we had all that record setting rainfall at the start of our season. things are extremely dry. you can see the wind warning. it starts at 3:00 a.m. tomorrow until 9:00 a.m. on thursday. these areas in orange, that's where we'll see the wind advisory in effect in the south bay and nts. 40 to 60-miles-per-hour. that could take down some powered lines, some trees, lower elevations, 15 to 35. >> 40 to 50 in the mountains, santa rosa, napa, 26 to 37 miles an hour. through tomorrow afternoon, you can see how this wind will be picking up. and again, this comes on top of the driest january on record in san jose. we only had trace amounts. last time it was this dry, it was 2015. >>> it's been five grueling days and her family is desperate to find her. lexus gabe of oakley disappeared without a trace last week. her

of confidence in the pfizer team. luz: luz peÑa, abc 7 news. liz: a new bill could make every california worker get vaccinated against covid-19. the proposal is by an assembly woman in oakland and it would require businesses to make sure employers are in compliance. ryan curry explains that the bill is getting mixed reaction. ryan: every worker in california vaccinated. that is the goal of a new bill proposed by bucky wicks. >> people have been experiencing so much whiplash when it comes to testing guidelines and mask mandate and vaccine guidance. ryan:re serar again covid-19. all businesses would have to require employees and contractors to get the vaccine. it comes after the supreme court ruled against a vaccine mandate proposed by the biden administration but weeks thanks this plan is legal. >> people are craving stability and we know enough about the pandemic that we can make this happen, we can make the stability happen together. ryan: the plan is being met with mixed reviews. >> i do not like the idea of govern

oil backing off big news today earnings from pfizer, harley, dupont peloton is slashing the outlook, replacing the ceo. >>> plus it was the biggest chip deal in history, the deal collapses due to significant regulatory challenges. >>> pfizer getting a boost from covid vaccine sales. >>> john foley is stepping down as peloton ceo, balely a wholesale restructure of the board. they do guide down on full-year revenue. foley on the call saying he has made some missteps. >> just the epitome of a boom/bust, moving fast to try to expand capacity into unprecedented demand, and then, you know, arguably having too much confidence. that seems to be the short version of the story along the way, a lot of criticism about spending, manage, all the rest of it. you know, you just don't know what the run rate is it's a interesting shift he also still controls voting -- >> he has 40% voting listen, somebody close to foley this morning tells me this is not unexpected, that he has been interested in or focused on potentially no longer being ceo. this is not necessarily in their view a sudden move in the s

how big is it expected to be, louise how much money does pfizer actually make on it? 12 >> okay, that's a harder onion to peel back the vaccine is partnered with biontech with pfizer right now it is 50/50. from the sales perspective going forward, this year, probably $36 billion. contract for 31 billion doses. going forward, it could sustain tens of billions of dollars of sales. people are looking for vaccine to be $8 billion of sales in 2026 a lot of upside for street expectation for the pfizer covid franchise. >> what about the anti-viral we don't hear a lot about it >> not yet we will. the anti-viral right now is over $7 billion of doses that are contracted not all is public. this is an estimate based on what we see publicly right now, consensus has it at $22 billion of sales i think this could be a big product. similar to tamiflu or other products and the long shelf life, it could be stockpiled by governments. i think we will see that over time >> we forget because we have been singularly focused on the pandemic for the last two years. louise, we forget diabetes i

kumasi: a push from pfizer to authorize vaccines for young children. parents sharing personal stories of how much it will mean for their everyday lives. reggie: they live look outside, it is 627 time. we have a nice little sunrise going and we will be right back. okay, it's go time. team usa on the largest gig-speed network. which means this mega fan never misses a second. it's gig-speed wifi that's “mikaela shiffrin” fast. ok, that's fast! speed's cool, but does yours block threats? yup, even for these upstairs all-nighters rocking wifi speeds faster than a gig. can your internet do that? learn more about gig-speed wifi, or get started with xfinity internet for $19.99 a month for 12 months. click, call, or visit a store today. ♪s you back. don't settle for silver. #1 for diabetic dry skin #1 for psoriasis symptom relief and #1 for eczema symptom relief. gold bond. champion your skin. >> building a better bay area, moving forward, finding solutions. this is abc 7 news. kumasi: the extreme winter storm stretching 2000 miles. look at this live look

but that's what could prompt pfizer to make that a three-dose vaccine. so it's intriguing and a little unclear why they're doing this now. >> and it's that uncertainty that has fueled some of the vaccine hesitancy for parents. even for kids who are already eligible. right now only 22% of children ages 5 to 11 are fully vaccinated. i wonder what percentage of kids do we need onboard to really make a significant impact here in the overall fight? >> we want everybody onboard. we want the entire country on board. and when i speak to my patients in clinic, the few who are still unvaccinated, i tell them that i know that this vaccine and our vaccines are super effective and super safe. so if we're going to tell our parents of little kids in this country that they need to vaccinate their children, we need to have the same kind of data. we can't go to them with sort of, well, we have some data that supports this. we need to tell them that we have robust data. so i want to make sure that when finally the fda decides on this, that they are evaluating the full set

this could change because pfizer acquired more of the pie. how is that going to happen and can fiserv acquire block? the ceo joins us in a fox business exclusive. the price indicates the bloom could be fading off the road -- the rose. i don't see the world going back to old-school banking. how should investors view your position? >> our job is to support financial institutions, credit unions while driving commerce. where a company designed to serve all forms of money movement, embedded in innovation and we love to innovate with our clients. liz: part of the innovation is acquisition of sintech. what does this do for your customers and is your customer base growing to the point you see people won't turn back to old-school banking? >> it designed financial institutions and financial institutions are our core in terms of how we think of serving their clients. very large business with clover which has been exclusive in growth and volume it the 50% mark. it is complementary technology preparing financial institutions for the digital transformation

how did you come in on pfizer and motor in a? >> first thing i did was i was putting out feelers to the big players. and 9 site we see merck was not successful but those were two of the first companies i reached out to and i was looking at small companies that i thought this is really neat and when i started this i thought i was going to try to get in the room with these companies come into zoom meetings and experience things in real time but i was completely shut out. there is that save it until you make it attitude which is i can do this, i'm on the biggest story of my life and i will succeed and doors were being shut, it is a very secretive company and i was frustrated, give a quote somewhere else and not talking to me so it became a strategic thing, how do i get the information i need and step-by-step i started building more and more sources within the government because companies were talking to the government and sending emails. they wanted to tell the story and that became my way in and the threat of the book which was the

but researchers stress the pfizer vaccine still protected against severe disease. the most critical measure. >> i think it's likely that -- that this could either be fixed by changing dose or giving a boost. >> reporter: david, we've seen how effective the third shot is in adults. right now, boosters are already recommended for kids 12 and older. and pfizer now says they are testing that third dose in children under 11. david? >> stephanie ramos, thank you. >>> also news tonight from the u.n.'s alarming new report on climate change. scientists now warning it is worse than previously thought, that the window is, quote, rapidly closing to avoid its deadly consequences. in fact, they say nearly half the world's population living in the so-called danger zone now. the report finding that even if warming is limited to 2.7 degrees fahrenheit, which has been a global goal, still, up to 14% of species will face a very high risk of extinction shun. and in some regions of the world, food and water will become increasingly scarce. >>> when we come back here on a monday night,

pfizer very explosively told its biotech partner in germany we don't think we're going to do a covid vaccine right now but of course they were able to put it that's the big story is that pfizer actually took steps and did the vaccine but the other companies, they lost what would have been for pfizer one of its biggest products of the year. so it makes you wonder about that sort of common view that vaccines are not ,moneymakers. maybe they are and when i was trying to get the data to look at how many how much companies profit from vaccines wastough . you're going to make more money from rare diseases, from cancer medicine but clearly it's a good gamble >> and if they have all the of the intentions, having that market is so important because infectious diseases are a much bigger problem in the global south. the reason we wrote about the malaria vaccine, it took 30 years to make a vaccine and there are almost no players and that and now thatthey have it the financing is so difficult . they have to commit to buying millions of doses so that african kids can live. it's a messed up system

pfizer seeks approval to inoculate children under 5. why some kids may need three shots. >>> well, good morning, and good to be with you. i'm anne-marie green. this morning more than 90 million people in 21 states are in the path of a massive winter storm. the national weather service has

whit johnson is at pfizer headquarters with the latest. good morning, whit. >> reporter: michael, good morning. this process now moves to an fda advisory panel meeting in a couple of weeks. if the pfizer vaccine is authorized for kids under 5, the cdc would then give the final green light and we could see those first shots by the end of the month. this morning, a major step towards vaccinating america's youngest children against covid. pfizer requesting emergency use authorization for kids 6 months to 5 years old. >> i think parents should feel good that as we so slowly work our way down in ages and continue to see a safe and effective vaccine that will also be true here. >> reporter: it is now submitting the trial data for just two doses citing an urgent public health need. federal regulators reportedly asking pfizer to move forward despite a lower immune response in 2 to 4-year-olds. the shots are 1/10th the strength of adult doses. >> there is an urgent need to get our younger kids immunized and protected against covid, but we can't let

why pfizer is now delaying its application to expand its vaccine to children under 5. our medical experts are standing by. >>> and also breaking today, president biden's supreme court short list even shorter now down to just three. who we're hearing the top contenders are right now and when the interview process might get started. when the interview process might get started. that liberty mutual customizes car insurance so you only pay for what you need, and we gotta do it fast. [limu emu squawks] woo! thirty-four miles per hour! new personal record, limu! [limu emu squawks] he'll be back. only pay for what you need. ♪ liberty, liberty, liberty, liberty. ♪ what happens when we welcome change? only pay for what you need. we can make emergency medicine possible at 40,000 feet. instead of burning our past for power, we can harness the energy of the tiny electron. we can create new ways to connect. rethinking how we communicate to be more inclusive than ever. with app, cloud and anywhere workspace solutions, vmware helps companies navigate change. faster. vmware. welco

cooper group >>> we have breaking news on pfizer's covid vaccine let's bring in meg for that story. meg? >> well, everybody was waiting this morning for pfizer and the fda to put out data on the covid vaccine for kids under age five. now the fda and pfizer are saying that is all going to be delayed as they wait for the third dose data in this trial. essentially back to the original plan but we had been expecting that we're going to see data on two doses this morning because both pfizer and federal health officials signalled there were enough data because of the omicron surge to show that two doses make a big difference here however, according to both the agency and the company, more data has emerged suggesting they should wait to see the third dose so they're delaying the fda advisory committee set for tuesday. pfizer saying in a statement, quote, given the study's advancing at a rapid pace, the companies will wait for the three-dose data as they believe it may provide a higher level of protection in this age group this is disappointing for a lot of parents who expected to happen so

do you think pfizer may have jumped the gun here? >> i think pfizer took a gamble, and are now realizing that that gamble was probably not the right decision and are rethinking their strategy. >> reporter: for adults each dose is 30 micrograms. for the youngest children, each dose is three. pfizer said in december two doses for the kids did not generate a strong enough immune response in its trial. days ago, pfizer's ceo seemed confident the fda would sign off on two doses while awaiting more data for a third. >> i think that they will be pleased with the data, and they will approve. >> reporter: but the wait now drags on for families like aaron par ness and his 3-year-old son, bailey. >> it's really frustrafrustrati. we were looking forward to having hmm vaccinated as soon as we do. >> reporter: pfizer expects data for the third dose by early april, so it could be two months before the vaccine is authorized. moderna says it could have data for kids 2 to 5 years old by march. >> thanks to gabe for that reporting. >>> a butterfly sanc

pfizer had submitted its application months earlier. we know at the time pfizer received full approval, but dharna had not finished its application. so it has taken longer for the fda to review thousands of pages and data points to make this decision. emily: let's talk about what is coming next. as a mom, i'm waiting for a vaccine for kids under five. do we have an eight on that? i've heard reports about march. riley: we have been waiting for the data. they provided an update in december that they are going to change the clinical trial of a three dose regimen instead of two in the under five cohort. but we are hearing signals from dr. anthony fauci, from a member of pfizer's board who formally sat at the top position of the fda that they expected to come in the next month or so. one thing you might want to consider as a parent is is it going to be three dose regimen or to dose regimen? in the wake of omicron, we are seeing it as much harder to prevent some to medic covid cases, including among children with just two doses. that is why m

pfizer's vaccine for children five and under has been pushed back. we will tell you what that means your parents. election day -- tuesday's special election in san francisco has somethin okay, it's go time. team usa on the largest gig-speed network. which means this mega fan never misses a second. it's gig-speed wifi that's “mikaela shiffrin” fast. ok, that's fast! speed's cool, but does yours block threats? yup, even for these upstairs all-nighters rocking wifi speeds faster than a gig. can your internet do that? learn more about gig-speed wifi, or get started with xfinity internet for $19.99 a month for 12 months. click, call, or visit a store today. kristen: with just days to go into the san francisco unified recall election, we are taking a look at citizens voting -- at people voting in the election for the first time. larry: noncitizens are able to vote in the election and there is a new push to allow immigrants to vote. kristen: this comes amid a push of legislation to make it harder to vote as we feature black americans who fought for that

pfizer expected to ask for authorization for children under 5. and cnn on the front lines. we're live in ukraine near the russian border. the u.s. again saying that they're trying to ease tensions as the kremlin gets no promises of backing off. plus -- one of the goats calls it quits. after 22 seasons, seven super bowl rings, tom brady bows out. his message to his no doubt deflated fans as he announces his retirement his way. welcome to "the lead." we start in the health lead. pfizer expected to ask the fda to authorize its two-dose vaccine regimen for kids as young as 6 months, as early as today. if authorized, the lower dose option could be available to kids younger than 5 years old within weeks. right now nearly 64% of the total u.s. population is fully vaccinated, but vaccination rates are lowest amongst children, according to the cdc. about 56% of children ages 12-17 are fully vaccinated. a number that drops to about 22% when you look at kids between 5 and 11 years old. now as cnn's nick watt reports, the fda is hoping authorization for toddlers will help convince pare

that's less than the previous week but still extremely high pfizer for now calling for two lower-dose shots for the youngest group. if approved, the first injections could begin within weeks but the news comes with a nagging dose of reality, reluctance of among many parents to have their kids vaccinated tom costello now with late details >> reporter: with 3.5 million new pediatric covid cases, january alone, the potential that shots could be going into very young arms within a month is welcome news for millions of parents. >> every day i'm worried about them contracting covid. i would say that we're very cautious. >> reporter: in maryland, the cross family has three kids, two under the age of 5. >> as a working parent, i want them vaccinated so that we are not dealing with this child care gap of constantly having to have our kids out of school and day care. >> reporter: pfizer today requesting emergency fda authorization for a two-shot vaccine dose at one-tenth the adult dose for kids 6 months to 5 years, as it continues researching whether a third dose provides even more protection c

doctors are clambering for two newly approved antiviral pills made by pfizer and merck. the pfizer pill, which is considered to be the go-to over merck's version, is not yet at full production and those pills take six to eight months to manufacture. >> we shouldn't be dealing with such basic principles as tests and therapies three years into a pandemic. these should be issues that have already been resolved. >> reporter: as a result, doctors are having to ration those medicines for the patients who are highest risk and most vulnerable to covid. last month the white house indicated it was working with pfizer to speed up its production of antiviral pills. reporting live, bob redell, "today in the bay." >> thank you so much. >>> 6:03, and developing for you this morning, we have more on what's going on with covid cases. some oakland teachers are staging a hunger strike from the plans to close up to eight schools and merge three others. yesterday people were marching from westlake middle school to the district's offices. they believe the closures will unfairly affect black s